<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Dalal S</submitter><funding>BLRD VA</funding><funding>NHLBI NIH HHS</funding><funding>National Institutes of Health</funding><funding>Department of Veterans Affairs</funding><funding>National Heart Lung and Blood Institute</funding><pagination>121216</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9784153</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>312</volume><pubmed_abstract>&lt;h4>Aims&lt;/h4>Pretreatment with ubiquitin (UB) associates with preservation of heart function 3 days post-ischemia/reperfusion (I/R) injury. This study investigated the cardioprotective potential of exogenous UB late after myocardial I/R injury. To enhance the clinical relevance, UB treatment was started at the time of reperfusion and continued for 28 days post-I/R.&lt;h4>Main methods&lt;/h4>Mice underwent ligation of the left anterior descending coronary artery for 45 min. At the time of reperfusion, mice were treated with UB or saline which was continued until 28 days post-I/R. Heart function was measured at 3, 7, 14 and 28 days post-I/R using echocardiography. Biochemical parameters of the heart and serum cytokines/chemokines levels were measured 28 days post-I/R.&lt;h4>Key findings&lt;/h4>I/R decre</pubmed_abstract><journal>Life sciences</journal><pubmed_title>Post-ischemic cardioprotective potential of exogenous ubiquitin in myocardial remodeling late after ischemia/reperfusion injury.</pubmed_title><pmcid>PMC9784153</pmcid><funding_grant_id>R15 HL141947</funding_grant_id><funding_grant_id>I01 BX004045</funding_grant_id><funding_grant_id>R21 HL092459</funding_grant_id><funding_grant_id>R15 HL156214</funding_grant_id><pubmed_authors>Dalal S</pubmed_authors><pubmed_authors>Singh K</pubmed_authors><pubmed_authors>Shook PL</pubmed_authors><pubmed_authors>Singh M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Post-ischemic cardioprotective potential of exogenous ubiquitin in myocardial remodeling late after ischemia/reperfusion injury.</name><description>&lt;h4>Aims&lt;/h4>Pretreatment with ubiquitin (UB) associates with preservation of heart function 3 days post-ischemia/reperfusion (I/R) injury. This study investigated the cardioprotective potential of exogenous UB late after myocardial I/R injury. To enhance the clinical relevance, UB treatment was started at the time of reperfusion and continued for 28 days post-I/R.&lt;h4>Main methods&lt;/h4>Mice underwent ligation of the left anterior descending coronary artery for 45 min. At the time of reperfusion, mice were treated with UB or saline which was continued until 28 days post-I/R. Heart function was measured at 3, 7, 14 and 28 days post-I/R using echocardiography. Biochemical parameters of the heart and serum cytokines/chemokines levels were measured 28 days post-I/R.&lt;h4>Key findings&lt;/h4>I/R decre</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jan</publication><modification>2025-04-20T09:18:56.182Z</modification><creation>2025-04-20T09:18:56.182Z</creation></dates><accession>S-EPMC9784153</accession><cross_references><pubmed>36435225</pubmed><doi>10.1016/j.lfs.2022.121216</doi></cross_references></HashMap>